A citation-based method for searching scientific literature

Brendan M Everett, Nancy R Cook, Daniel I Chasman, Maria C Magnone, Maria Bobadilla, Nader Rifai, Paul M Ridker, Aruna D Pradhan. Clin Chem 2013
Times Cited: 18







List of co-cited articles
190 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies.
Roman Pfister, Stephen Sharp, Robert Luben, Paul Welsh, Inês Barroso, Veikko Salomaa, Aline Meirhaeghe, Kay-Tee Khaw, Naveed Sattar, Claudia Langenberg,[...]. PLoS Med 2011
69
72

Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study.
Martin Magnusson, Amra Jujic, Bo Hedblad, Gunnar Engström, Margaretha Persson, Joachim Struck, Nils G Morgenthaler, Peter Nilsson, Christopher Newton-Cheh, Thomas J Wang,[...]. J Clin Endocrinol Metab 2012
98
55

Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity.
Kazutoshi Miyashita, Hiroshi Itoh, Hirokazu Tsujimoto, Naohisa Tamura, Yasutomo Fukunaga, Masakatsu Sone, Kenichi Yamahara, Daisuke Taura, Megumi Inuzuka, Takuhiro Sonoyama,[...]. Diabetes 2009
188
55

Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile.
Ian J Neeland, Benjamin R Winders, Colby R Ayers, Sandeep R Das, Alice Y Chang, Jarett D Berry, Amit Khera, Darren K McGuire, Gloria L Vega, James A de Lemos,[...]. J Am Coll Cardiol 2013
71
50

Impact of obesity on plasma natriuretic peptide levels.
Thomas J Wang, Martin G Larson, Daniel Levy, Emelia J Benjamin, Eric P Leip, Peter W F Wilson, Ramachandran S Vasan. Circulation 2004
614
44

Natriuretic peptides enhance the oxidative capacity of human skeletal muscle.
Stefan Engeli, Andreas L Birkenfeld, Pierre-Marie Badin, Virginie Bourlier, Katie Louche, Nathalie Viguerie, Claire Thalamas, Emilie Montastier, Dominique Larrouy, Isabelle Harant,[...]. J Clin Invest 2012
109
44

NH2-terminal pro-brain natriuretic peptide and risk of diabetes.
Mariana Lazo, J Hunter Young, Frederick L Brancati, Josef Coresh, Seamus Whelton, Chiadi E Ndumele, Ron Hoogeveen, Christie M Ballantyne, Elizabeth Selvin. Diabetes 2013
63
44

Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes.
Marica Bordicchia, Dianxin Liu, Ez-Zoubir Amri, Gerard Ailhaud, Paolo Dessì-Fulgheri, Chaoying Zhang, Nobuyuki Takahashi, Riccardo Sarzani, Sheila Collins. J Clin Invest 2012
522
38

Atrial natriuretic peptide induces postprandial lipid oxidation in humans.
Andreas L Birkenfeld, Petra Budziarek, Michael Boschmann, Cedric Moro, Frauke Adams, Gabriele Franke, Michel Berlan, Marie A Marques, Fred C G J Sweep, Friedrich C Luft,[...]. Diabetes 2008
87
33

Reciprocal regulation of natriuretic peptide receptors by insulin in adipose cells.
Hideaki Nakatsuji, Norikazu Maeda, Toshiyuki Hibuse, Aki Hiuge, Ayumu Hirata, Yohei Kuroda, Ken Kishida, Shinji Kihara, Tohru Funahashi, Iichiro Shimomura. Biochem Biophys Res Commun 2010
38
33

N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.
Michael H Olsen, Tine W Hansen, Marina K Christensen, Finn Gustafsson, Susanne Rasmussen, Kristian Wachtell, Knut Borch-Johnsen, Hans Ibsen, Torben Jørgensen, Per Hildebrandt. Hypertension 2005
124
27

The atrial natriuretic peptide and guanylyl cyclase-A system modulates pancreatic beta-cell function.
Ana B Ropero, Sergi Soriano, Eva Tudurí, Laura Marroquí, Noelia Téllez, Birgit Gassner, Pablo Juan-Picó, Eduard Montanya, Ivan Quesada, Michaela Kuhn,[...]. Endocrinology 2010
33
27

Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?
Olga Pivovarova, Özlem Gögebakan, Nora Klöting, Andrea Sparwasser, Martin O Weickert, Isam Haddad, Victoria J Nikiforova, Andreas Bergmann, Michael Kruse, Anne-Cathrin Seltmann,[...]. J Clin Endocrinol Metab 2012
63
27

Atrial natriuretic peptide and adiponectin interactions in man.
Andreas L Birkenfeld, Michael Boschmann, Stefan Engeli, Cedric Moro, Ayman M Arafat, Friedrich C Luft, Jens Jordan. PLoS One 2012
53
27

Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.
Sandeep R Das, Mark H Drazner, Daniel L Dries, Gloria L Vega, Harold G Stanek, Shuaib M Abdullah, Russell M Canham, Anne K Chung, David Leonard, Frank H Wians,[...]. Circulation 2005
268
27

Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients.
P Dessì-Fulgheri, R Sarzani, P Tamburrini, A Moraca, E Espinosa, G Cola, L Giantomassi, A Rappelli. J Hypertens 1997
138
27

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
D R Matthews, J P Hosker, A S Rudenski, B A Naylor, D F Treacher, R C Turner. Diabetologia 1985
27

Natriuretic peptides: a new lipolytic pathway in human adipocytes.
C Sengenès, M Berlan, I De Glisezinski, M Lafontan, J Galitzky. FASEB J 2000
184
27


Control of lipolysis by natriuretic peptides and cyclic GMP.
Max Lafontan, Cédric Moro, Michel Berlan, François Crampes, Coralie Sengenes, Jean Galitzky. Trends Endocrinol Metab 2008
146
22

Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue.
C Moro, E Klimcakova, K Lolmède, M Berlan, M Lafontan, V Stich, A Bouloumié, J Galitzky, P Arner, D Langin. Diabetologia 2007
75
22

Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass.
Speranza Rubattu, Sebastiano Sciarretta, Giuseppino Massimo Ciavarella, Vanessa Venturelli, Paola De Paolis, Giuliano Tocci, Luciano De Biase, Andrea Ferrucci, Massimo Volpe. J Hypertens 2007
31
22

Expression of natriuretic peptide receptors in human adipose and other tissues.
R Sarzani, P Dessì-Fulgheri, V M Paci, E Espinosa, A Rappelli. J Endocrinol Invest 1996
161
22

B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men.
B B Heinisch, G Vila, M Resl, M Riedl, B Dieplinger, T Mueller, A Luger, G Pacini, M Clodi. Diabetologia 2012
32
22

Effect of weight loss after weight loss surgery on plasma N-terminal pro-B-type natriuretic peptide levels.
Annabel Chen-Tournoux, Abigail May Khan, Aaron L Baggish, Victor M Castro, Marc J Semigran, Elizabeth L McCabe, George Moukarbel, Jason Reingold, Sofia Durrani, Gregory D Lewis,[...]. Am J Cardiol 2010
39
22

Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans.
Andreas L Birkenfeld, Michael Boschmann, Cedric Moro, Frauke Adams, Karsten Heusser, Gabriele Franke, Michel Berlan, Friedrich C Luft, Max Lafontan, Jens Jordan. J Clin Endocrinol Metab 2005
114
22

The atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population.
Valentina Cannone, Angelo Baldassare Cefalu', Davide Noto, Christopher G Scott, Kent R Bailey, Giovanni Cavera, Michele Pagano, Michelangelo Sapienza, Maurizio R Averna, John C Burnett. Diabetes Care 2013
34
22

Physiological role of silent receptors of atrial natriuretic factor.
T Maack, M Suzuki, F A Almeida, D Nussenzveig, R M Scarborough, G A McEnroe, J A Lewicki. Science 1987
664
22

GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure.
Minsuk Kim, Mathew J Platt, Tadao Shibasaki, Susan E Quaggin, Peter H Backx, Susumu Seino, Jeremy A Simpson, Daniel J Drucker. Nat Med 2013
281
22

Atrial natriuretic peptide regulates lipid mobilization and oxygen consumption in human adipocytes by activating AMPK.
Sandra C Souza, Mary D L Chau, Qing Yang, Marie-Soleil Gauthier, Kevin B Clairmont, Zhidan Wu, Jesper Gromada, William P Dole. Biochem Biophys Res Commun 2011
21
22

Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies.
Abigail May Khan, Susan Cheng, Martin Magnusson, Martin G Larson, Christopher Newton-Cheh, Elizabeth L McCabe, Andrea D Coviello, Jose C Florez, Caroline S Fox, Daniel Levy,[...]. J Clin Endocrinol Metab 2011
106
22

Neprilysin, obesity and the metabolic syndrome.
K F Standeven, K Hess, A M Carter, G I Rice, P A Cordell, A J Balmforth, B Lu, D J Scott, A J Turner, N M Hooper,[...]. Int J Obes (Lond) 2011
88
22

Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells.
Cedric Moro, Jean Galitzky, Coralie Sengenes, François Crampes, Max Lafontan, Michel Berlan. J Pharmacol Exp Ther 2004
61
22

Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes.
Julie A Lovshin, Annette Barnie, Ariana DeAlmeida, Alexander Logan, Bernard Zinman, Daniel J Drucker. Diabetes Care 2015
89
22

Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome.
Nina Schlueter, Anita de Sterke, Diana M Willmes, Joachim Spranger, Jens Jordan, Andreas L Birkenfeld. Pharmacol Ther 2014
78
22


B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies.
Emanuele Di Angelantonio, Rajiv Chowdhury, Nadeem Sarwar, Kausik K Ray, Reeta Gobin, Danish Saleheen, Alexander Thompson, Vilmundur Gudnason, Naveed Sattar, John Danesh. Circulation 2009
250
22

Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.
Osamu Tsukamoto, Masashi Fujita, Mahoto Kato, Satoru Yamazaki, Yoshihiro Asano, Akiko Ogai, Hidetoshi Okazaki, Mitsutoshi Asai, Yoko Nagamachi, Norikazu Maeda,[...]. J Am Coll Cardiol 2009
178
22

Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals.
Thomas J Wang, Martin G Larson, Michelle J Keyes, Daniel Levy, Emelia J Benjamin, Ramachandran S Vasan. Circulation 2007
152
16

Increase in circulating insulin induced by atrial natriuretic peptide in normal humans.
D E Uehlinger, P Weidmann, M P Gnädinger, L Hasler, C Bachmann, S Shaw, B Hellmüller, R E Lang. J Cardiovasc Pharmacol 1986
52
16

Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension.
Speranza Rubattu, Giada Bigatti, Anna Evangelista, Chiara Lanzani, Rosita Stanzione, Laura Zagato, Paolo Manunta, Simona Marchitti, Vanessa Venturelli, Giuseppe Bianchi,[...]. J Am Coll Cardiol 2006
97
16

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.
T Sudoh, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1990
678
16

Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations.
Aline Meirhaeghe, Manjinder S Sandhu, Mark I McCarthy, Pascal de Groote, Dominique Cottel, Dominique Arveiler, Jean Ferrières, Christopher J Groves, Andrew T Hattersley, Graham A Hitman,[...]. Hum Mol Genet 2007
56
16

Genetic disruption of atrial natriuretic peptide receptor-A alters renin and angiotensin II levels.
S J Shi, H T Nguyen, G D Sharma, L G Navar, K N Pandey. Am J Physiol Renal Physiol 2001
53
16

Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.
Toshio Nishikimi, Koichiro Kuwahara, Kazuwa Nakao. J Cardiol 2011
103
16

Metabolic actions could confound advantageous effects of combined angiotensin II receptor and neprilysin inhibition.
Andreas L Birkenfeld, Frauke Adams, Christoph Schroeder, Stefan Engeli, Jens Jordan. Hypertension 2011
22
16

Influence of sex and hormone status on circulating natriuretic peptides.
Carolyn S P Lam, Susan Cheng, Karen Choong, Martin G Larson, Joanne M Murabito, Christopher Newton-Cheh, Shalender Bhasin, Elizabeth L McCabe, Karen K Miller, Margaret M Redfield,[...]. J Am Coll Cardiol 2011
87
16

Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.
Andreas L Birkenfeld, Gerald I Shulman. Hepatology 2014
344
16

Prospective associations of B-type natriuretic peptide with markers of left ventricular function in individuals with and without type 2 diabetes: an 8-year follow-up of the Hoorn Study.
Maria H Kroon, Katja van den Hurk, Marjan Alssema, Otto Kamp, Coen D A Stehouwer, Ronald M A Henry, Michaela Diamant, Frans Boomsma, Giel Nijpels, Walter J Paulus,[...]. Diabetes Care 2012
21
16

17β-Estradiol-induced interaction of ERα with NPPA regulates gene expression in cardiomyocytes.
Shokoufeh Mahmoodzadeh, Thi Hang Pham, Arne Kuehne, Britta Fielitz, Elke Dworatzek, Georgios Kararigas, George Petrov, Mercy M Davidson, Vera Regitz-Zagrosek. Cardiovasc Res 2012
23
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.